TORONTO, Dec. 11, 2018 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in technology solutions for the regulated cannabis industry, announced today that its Board of Directors has appointed Company founder, Howard Mann, as CEO effective immediately. Mr. Mann has also been elected to the Board of Directors. Outgoing CEO, Dr. Michael Murphy, will stay on as Chairman of the Board and continue to work closely with executive management to ensure a smooth transition.
Howard Mann founded Alternate Health in 2014 and was instrumental in the company's growth and public listing at the beginning of 2017. A committed supporter of the company, Mr. Mann has not sold a single share since listing, demonstrating his confidence in the future of the company. His extensive background in software development, marketing, and intellectual property provides the expertise the Company requires to accomplish its strategic priorities and drive profitability. With his sharp entrepreneurial instincts and business acumen, Mr. Mann is focused on delivering consistent revenue from the Company's assets.
"Given the current favourable changes in the regulatory atmosphere of the cannabis industry, the Company is ready to take a bold step towards capturing this market," says incoming CEO Howard Mann. "Using our breadth of experience, we will reposition Alternate Health as a global leader in legal cannabis."
"Alternate Health is set to expand throughout California's multibillion dollar cannabis distribution business," says Mr. Mann. "We will aggressively position Alternate Health as a leading distributor and infrastructure provider to the world's largest cannabis market."
About Alternate Health
Alternate Health (CSE: AHG, OTCQB: AHGIF) is an international cannabis company, focusing on technology and value-added services. Alternate Health's industry-leading software systems provide the platform for the company's diverse operations, including distribution and the first medial cannabis software portal approved by the Florida Department of Health.
Alternate Health's corporate office is located in Toronto, Canada, with additional offices in Venice and Humboldt County, California and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders. Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals, AXIM Biotechnologies Inc., and Canopy Growth Corporation. For more information about Alternate Health Corp., visit www.alternatehealth.ca.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects, anticipated growth and potential revenues, derived from the Bionic Bee asset purchase are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.
SOURCE Alternate Health Corp.
For further information: Investor Contact: George Mull | Director, President, 1.416.607.5757
Related Links
http://www.alternatehealth.ca/
